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Abstract
Epithelial to mesenchymal transition (EMT) is a key process during embryonic development and disease development and
progression. During EMT, epithelial cells lose epithelial features and express mesenchymal cell markers, which correlate with
increased cell migration and invasion. Transforming growth factor-b (TGF-b) is a multifunctional cytokine that induces EMT
in multiple cell types. The TGF-b pathway is regulated by microRNAs (miRNAs), which are small non-coding RNAs regulating
the translation of specific messenger RNAs. Herein, we identified mir-99a and mir-99b as two novel TGF-b target miRNA
genes, the expression of which increased during TGF-b induced EMT of NMUMG cells. Mir-99a and mir-99b inhibition
decreased TGF-b activity by inhibiting SMAD3 phosphorylation, resulting in decreased migration and increased proliferation
in response to TGF-b. However, mir-99a and mir-99b inhibition was insufficient to block TGF-b induced EMT of NMUMG
cells. Mir-99a and mir-99b over-expression in epithelial NMUMG cells resulted in increased proliferation, migration and
fibronectin expression, while E-cadherin and ZO-1 expression were negatively regulated. In conclusion, we identified mir-
99a and mir-99b as two novel modulators of TGF-b pathway that alter SMAD3 phosphorylation, in turn altering cell
migration and adhesion of mesenchymal NMUMG cells. The effect of mir-99a and mir-99b over-expression on NMUMUG
proliferation is dependent upon the epithelial or mesenchymal status of the cells. Our study suggests that mir-99a and mir-
99b may function as modulators within a complex network of factors regulating TGF-b induced breast epithelial to
mesenchymal transition, as well as proliferation and migration of breast cancer cells, providing a possible target for future
translationally oriented studies in this area.
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Introduction
Epithelial to mesenchymal transition (EMT) is a complex
process, which involves cytoskeletal remodeling and cell–cell and
cell–matrix adhesion as well as transcriptional regulation, leading
to the transition from a polarized epithelial phenotype to an
elongated fibroblast-like phenotype. TGF-b is a secreted cytokine
that regulates a variety of processes in development and cancer
including epithelial to mesenchymal transition [1,2]. The TGF-b
pathway cross-talks with other important molecular pathways,
such as Wnt, and also acts thorough mTOR, which is activated
through phosphorylation by TGF-b itself. In turn mTOR
negatively regulates TGF-b signaling through SMAD3 inhibition.
Comparison of the genomes of different species has shown that
a large proportion of the genome is devoted to controlling gene
transcription. MicroRNAs (mirnas) are single stranded RNAs, 19–
25 nucleotides in length that are generated from endogenous
hairpin shaped transcripts [3]. Mirnas are regulatory genes that
inhibit gene expression of specific target genes, primarily by
binding to the 39 UTR of the specific mRNA [4–7]. They have
important roles in many biological processes such as cell
proliferation, differentiation and embryonic development as well
as in the development and progression of diseases [8–11].
Dicer is the key enzyme involved in mirna biogenesis and it also
plays a direct role in the process of EMT. Down-regulation of
DICER by miR-103/107 induces EMT of NMUMG cells, which
results in enhanced cell migration and metastatic properties [12].
Likewise, the maturation and processing of mirna has been
directly connected to the TGF-b pathway [13].
Mirnas are already known to be key regulators of the TGF-b
pathway [14–18]. For example, the mir-200 family of mirnas is
specifically down-regulated by TGF-b during EMT in normal
mouse mammary gland (NMUMG) cells, whereas up-regulation of
mir-200s in epithelial phase NMUMG cells completely abrogates
TGF-b pathway signaling and thus TGF-b mediated stimulation
of EMT [19–22]. Additionally, Mir-155 is a downstream mirna of
the TGF-b pathway that can modulate epithelial cell plasticity
[23]. mTOR is a target of mir-99a and mir-99b [24,25]. By
targeting mTOR, mir-99a and mir-99b inhibit proliferation of c-
Src-transformed cells and prostate cancer cells. [24,25]. However,
Li X et al. (2011) reported that mir-99a and mir-99b are over-
expressed in gastric carcinoma [26], which indicates that mir-99a
and mir-99b may also act as oncomirs in different cell types.
Although mTOR plays a key role in cell proliferation and
differentiation, its inhibition with rapamycin does not affect
proliferation in some cell lines in vitro [27,28]. Herein, we focused
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play a functional role in modulating the TGF-b pathway and their
role on cell proliferation in epithelial NMUMG cells, which are
insensitive to rapamycin, versus mesenchymal NMUMG cells that
are instead rapamycin sensitive [28].
In our study we have identified mir-99a and mir-99b as two
novel downstream mirnas of the TGF-b pathway. The expression
of mir-99a and mir-99b was stimulated by TGF-b during TGF-b
induced EMT in NMUMG cells. The blockade of mir-99a and
mir-99b with LNA-knockdown probes inhibited TGF-b autocrine
activity in NMUMG cells through inhibition of Smad3
phosphorylation and consequently inhibited cell migration,
increased cell proliferation, yet failed to completely arrest
EMT. On the other hand, up-regulation of mir-99a and mir-
99b in NMUMG cells resulted in down-regulation of E-cadherin
and ZO-1, together with increased cell migration and prolifer-
ation. We have validated multiple targets of mir-99a and mir-99b
that are known to be involved in cell proliferation, and
differentiation, as well as chromatin remodeling. Some important
mir-99a and mir-99b effects such as E-cadherin and ZO-1 down-
regulation could be replicated by mTOR down-regulation using
a specific sirna. Thus, mTOR may be considered as a main
functional target of mir-99a and mir-99b among a rather broad
network of targets modulating different aspects of cellular
function. In particular, by negatively modulating TGF-b pathway
signaling and therefore epithelial and mesenchymal cell plasticity,
we speculate that mir-99a and mir-99b may prove to be critical
modulators of cancer development and progression. In addition,
we speculate that by down-regulating the mTOR gene, these
mirnas could perhaps counteract the over-activation of the
mTOR pathway that is seen in diseases such as Lymphangio-
leiomyomatosis (LAM) and certain cancers.
Materials and Methods
Cell lines
HELA, NMUMG, 4T1 cells were purchased from ATCC and
maintained in DMEM, 10% FBS (Gibco/Invitrogen, Carlsbad,
CA) and 1% antibiotics (Penicillin, Streptomycin) (Gibco/Invitro-
gen, Carlsbad, CA). NMuMG cells media were supplemented with
insulin (10 mg/ml) (Sigma-Aldrich, St. Louis, MO). 4T1 cells were
cultured with RPMI-1640 supplemented with 10% FBS.
CDNA retrotranscription and RT Real Time PCR
RNA was extracted from cell culture pellets using TRIZOL
reagent. 1 mg of RNA was retro-transcribed using the Super-
Script II reverse transcriptase kit (Invitrogen, Carlsbad, CA). The
cDNA was amplified with TaqMan (Roche,) in the presence of
gene specific primers and probes (Operon, Huntsville, AL) as
indicated. The primers sequence used is reported in the appendix
(Table 1).
Micrornas retro-transcription and Real Time PCR
For mirnas quantification, TaqMan microRNAs Assay was
used. For the retro-transcription 10 ng of total RNA was used and
retro-transcribed in 7.5 ml total volume reactions containing:
1.5 ml mirna specific primer (Applied Biosystems), 10 units of
RNAase inhibitor, and 25 units of multiscribe reverse retro-
transcriptase (Chen et al., 2005). Quantitative real-time PCR was
carried out using the Roche Light Cycler 480 and the Light Cycler
TaqMan Master Mix. Real Time PCR conditions were as follows:
95uC for 10 minutes, 45 cycles: 95uC for 10 seconds, 60uC for
30 seconds. Mirnas specific primer and probe were supplied by
Applied Biosystems.
Luciferase plasmids design
To confirm mir-99a and mir99b targets, a luciferase assay was
used. Part of the wild type 39UTR (WT-39-UTR) and mutated
39UTR (MUT-39UTR) of the hypothetical target gene messen-
ger RNA, containing the putative mir-99a and mir-99b binding
sites was amplified by PCR and inserted downstream of a
luciferase reporter gene in a PGL4.13 plasmid (Promega, San
Luis Obispo, CA). The mutated 39UTR (MUT-39-UTR) was
obtained by inserting 3 point mutations in the mir-99a and mir-
99b binding site, thus destroying the putative mirna/mRNA
interaction. To create the 39-UTR-MUT, a PCR approach was
used using specific primers covering the mir-99a and mir-99b
binding sites bearing the mutated bases. The sequence of the
primers used for the 39UTRs cloning is reported in appendix
(Table 2).
Luciferase assay
Hela cells were seed in 24 well plates (80000 cells per well) and
the next day transfected with 300 ng of the WT or MUT 39UTR
luciferase reporter construct, together with a mir-99a, mir-99b or
a scrambled precursor (final concentration 20 nM) (Dharmacon,
Lafayette, CO, USA) 50 ng of the renilla plasmid PGL-6.43
(Promega, San Luis Obispo, CA) was co-transfected into each
well and used as the transfection internal control. Cells were
collected 48 h after transfection, and luciferase activity was
measured with a dual-luciferase reporter assay (Promega, San
Luis Obispo, CA). The luciferase activity was normalized on the
Renilla luciferase activity and expressed as true ratio between the
luciferase activity of the WT-39UTR plasmid and the MUT-
39UTR plasmid. Every luciferase assay experiment was repeated
at least three times.
Adenoviral transduction
Adenoviral construct for wild type mTOR expression was
obtained from Christopher Rhodes (University of Chicago),
amplified in HEK-293A cells and used at MOI of 10. Western
blot was used to confirm the up-regulation of mTOR protein
[29,30].
Antibodies
MTOR antibodies were purchased from Cell Signaling,
ACTIN antibody from MP Biomedicals, CYCLIN D1, SM-22-
a, antibody from Santa Cruz Biotechnology, E-cadherin from BD
transduction, SMARCA5 antibody from Bethyl laboratories, ZO-
1 from invitrogen.
Table 1. Primers used for real time RT-PCR.
snai-1-s tggaaaggccttctctaggc
snai-1-as tcagcaaaagcacggttg
sip1-s tcactaatccgacagcttgc
sip1-as gggactctttcgtcatctttactg
slug-s tgcaagatctgtggcaagg
slug-as cagtgagggcaagagaaagg
fibronectin-s ccctgacactggagtgcttac
fibronectin-as ccgttcgtgggggtagtag
rRNA 18s-s aaatcagttatggttcctttggtc
rRNA 18s-as gctctagaattaccacagttatccaa
doi:10.1371/journal.pone.0031032.t001
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Cells were seeded at 50% confluence and the next day transfected
with mir-99a, mir-99b or a scrambled mirna precursor (final
concentration 80 nM) (Dharmacon) using lipofectamine 2000
(Gibco/Invitrogen, Carlsbad, CA). Fresh media was added 6 hour
later. 72 hours post transfection cells were lysed with Ripa buffer
(1XTBS, 1% Nonidet P-40, 0.5% sodium deoxycholate, 0.1% SDS,
0.004% sodium azide) (Sigma-Aldrich, St. Louis, MO), supplied with
phosphatase and protease inhibitors (PMSF solution, sodium
orthovanadate solution and protease inhibitor cocktail solution)
(Sigma-Aldrich, St. Louis, MO). B-ACTIN protein amount was
measured ineachwestern blotexperimentand used as loadingcontrol.
Cytofluorimetry and cell cycle analysis
Cells were seeded in 6 well plates at 40% confluency and, the next
day, transfected with the indicated siRNA or mirna (80 nM final
concentration) using lipofectamine 2000 (Gibco/Invitrogen, Carlsbad,
CA). Fresh media was added 6 hours after transfection. After 72 hours
cells were trypsinized, washed with PBS and fixed in ice with cold
70%/30% ethanol/PBS solution for 30 minutes. Cells were then
washed with PBS and resuspended in propidium iodium (20 mg/ml)
solution containing RNAse (200 mg/ml) for 309 at room temperature.
Cellular DNA content was determined with a FACScalibur
(Becton Dickinson) instrument.
Migration Assay: scratch assay
Cells were seed in 12 well plates at 50% confluency and the
next day transfected with mir-99a, mir-99b or a scrambled mirna
at a final concentration of 80 nM. Media was changed 6 hours
later. 72 hours post transfection, cell layer was scratched with
a p200 tip pipette. The healing process was followed for the
next 24 hours. The ability of the cells to close the wound
was expressed as true ratio between the area of the wound at
24 hours post scratch and the area of wound width right after the
scratch was done. Wound area was determined with Photoshop
software.
Cells adhesion assay
NMUMG cells were seed on a 12 wells plate and the next day
transfected with the indicated mirna inhibitor or control. 3 days
later cells were trypsinized and the same number of cells for each
sample was seeded into wells of 6 well plates. 3 hours later floating
cells were removed by two PBS washes and the adherent cells were
trypsinized and counted.
SIRNAs
SIRNA for mTOR and control sirna were bought from Applied
Biosystems and used at a final concentration of 20 nM.
Lipofectamine 2000 (Invitrogen) was used for the transfection.
Data analysis
Data are presented as means6SD. Statistical significance
between control and experimental samples was calculated using
Student’s t-test. Western blots are representative of three
independent experiments. Densitometry analysis was obtained
using Image J software.
Table 2. Primers used for 39UTR cloning.
Gene name Forward and reverse primers Size of the 39UTR
mTOR For 59-CCTTGTCTGTGCTTCCAGTG-39 382 bp
(NM_020009.1) Rev 59-ACGGGTGAGGTAACAGGATG-39
PAM For 59-CAGATCCTTTGTCTATGGAGAGG-39 530 bp
(NM_207215.2) Rev 59-TACAGGACAAACATTGATAGCTTTA-39
CDK7 For 59-GACGCACAATGGACAGTTTCAC-39 156 bp
(NM_009874.3) Rev 59-GAATTGTAAAATACATTTAATAAAAAT-39
EPC2 For 59-GGAAATTATGCATCTAGCACATT-39 380 bp
(NM_172663) Rev 59-CATTCTGAAACACCACTACACG-39
PHOX2B For 59-TGCGCAGTTTAGACATCTCTGT-39 487 bp
( NM_008888.2) Rev 59-CAAGTTAATGGTACACTCTTGGAAAA-39
CYP26B1 For 59-TTGCCCCTGTCCCATATTTA-39 807 bp
(NM_175475.2) Rev 59-CAGAACCCCAAACCCTTCC-39
FOXA1 For 59-GACCGAATTCCAAAATCCCAAT-39 249 bp
(NM_008259.3) Rev 59-GACAAATCACATCGATAAAAATTAACA-39
CALM For 59-TGAAGTAACATGTTGCATGTGG-39 420 bp
(NM_007589.4) Rev 59-TTGGAAAACAAATATACAACTTGG-39
BAZ2A For 59-GCCCTGAACATGCTGCTT-39 1360 bp
(NM_054078.2) Rev 59-TGCATAATATAAAGTCAATTCAAA-39
SMARCA5 For 59-GCATTTTTGTCTTATAATCACTAACTG-39 589 bp
(NM_053124.2) Rev 59-AAAGGCCATTCATCCAACAA-39
EPC2 For 59-GGAAATTATGCATCTAGCACATT-39 380 bp
(NM_172663) Rev 59-CATTCTGAAACACCACTACACG-39
CTDSPL For 59-CGTTCTTGCCACCACAAAC-39 672 bp
(NM_133710.2) Rev 59-ATCGGTGACAGGTGGTGTG-39
doi:10.1371/journal.pone.0031032.t002
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Mir-99a and mir-99b expression increased during TGF-b
induced EMT in NMUMG cells
When stimulated by TGF-b, NMUMG cells undergo EMT by
showing visible morphological changes within 24 hours, and the
EMT process can be considered complete in 3 days [31]
(Figure 1A,B): mesenchymal NMUMG cells adopted a spindle-
like shape which was correlated with actin reorganization,
decreased E-cadherin expression and increased a-SMA expres-
sion. We used RT-Real Time PCR to determine whether the
expression of mir-99a and mir-99b changes during TGF-b
induced EMT in NMUMG cells. As shown in Figure 1C, mir-
99a and mir-99b expression was higher in the mesenchymal versus
the epithelial phase of NMUMG. Thus, we postulated that these
mirnas may play specific functional roles in TGF-b stimulated
EMT. Mir-99a and mir-99b share most of their nucleotide
sequence and they are located in different chromosomes adjacent
to the let-7 family of micrornas (Figure 1D), which suggests an
evolutionary chromosome duplication.
Mir-99a and mir-99b are required for normal TGF-b
signaling in NMUMG cells
As mentioned above, the expression of mir-99a and mir-99b
increased during TGF-b induced EMT of NMUMG cells.
Therefore, we used using specific LNA-probes for mir-99a and
mir-99b to determine the effect of mir-99a and mir-99b blockade
on the TGF-b signaling pathway and on the EMT process.
NMUMG cells were transfected with the indicated LNA knock-
down probes and two days later transfected with 3TP-lux plasmid,
in which luciferase reporter gene expression is driven by a TGF-b
sensitive promoter [32]. NMUMG cells were then incubated
overnight with TGF-b and 24 hours later luciferase activity was
quantified. The blockade of mir-99a and mir-99b with LNA-probe
indeed inhibited the luciferase activity by about 50% (Figure 2A).
Next, we determined whether mir-99a and mir-99b blockade
affected cell proliferation and migration in mesenchymal phase
NMUMG cells. Cell proliferation of mesenchymal phase
NMUMG cells was stimulated by inhibiting mir-99a and mir-
99b with LNA-antisense probes (Figure 2B). TGF-b decreases
proliferation of NMUMG cells but mir-99a and mir-99b blockade
Figure 1. Mir-99a and mir-99b expression during TGF-b induced EMT of NMUMG cells. NMUMG cells were treated with TGF-b for 3 days
and RNA was collected for mir-99a and mir-99b quantification. (A) F-actin staining shows changes of the morphology of NMUMG cells. (B)
Quantification of mir-99a and mir-99b expression in TGF-b treated and untreated NMUMG cells (*=p,0.05). (C) Changes of E-cadherin, a-SMA, cyclin
D1 expression during EMT of NMUMG cells. (D) Genomic organization of mir-99a and mir-99b loci.
doi:10.1371/journal.pone.0031032.g001
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NMUMG cells, supporting the hypothesis that mir-99a and mir-
99b are necessary for normal TGF-b signaling.
Mir-99a and mir-99b inhibition also resulted in reduced cell
migration (Figure 2C,D) and less efficient adhesion (Figure 2E) of
mesenchymal phase NMUMG cells. Mir-99a and mir-99b
blockade also inhibited TGF-b induced cell migration of human
4T1 cells (Figure S1A,B).
To determine whether the decreased TGF-b activity was
accompanied with decreased SMAD3 phosphorylation, NMUMG
cells were transfected with mir-99a, mir-99b or control LNA-probe,
and pulsed 72 hours later with TGF-b recombinant protein.
SMAD3 phosphorylation was then quantified by Western blot.
Interestingly, SMAD3 phosphorylation by TGF-b was inhibited by
mir-99a and mir-99b blockade (Figure 3A,B)., suggesting that mir-
99a and mir-99b inhibition alters TGF-b pathway signaling by
inhibiting phosphorylation of SMAD3. However, even though mir-
99a and mir-99b blockade inhibited the TGF-b-SMAD3 pathway,
TGF-b induced EMT of NMUMG cells was not apparently
affected. Indeed, when cultured with TGF-b in the presence of mir-
99a and mir-99b LNA-antisense probes, NMUMG cells still lost
ZO-1 expression and assumed the morphological features of
mesenchymal cells as indicated by the pattern of expression of
filamentous actin (Figure 4A,B,C). Therefore, we concluded that
mir-99a and mir-99b modulate downstream TGF-b signaling in
NMUMG cells, affecting cell migration, adhesion and cell
proliferation and we also concluded but that mir-99a and mir-99b
are not needed for TGF-b induced EMT progression.
Mir-99a and mir-99b over-expression increased cell
motility and down-regulated E-cadherin and ZO-1 in
epithelial NMUMG cells
Since the expression of mir-99a and mir-99b increased in
NMUMG undergoing EMT (Figure 1C), and the blockade of mir-
99a and mir-99b with LNA probes significantly affected
mesenchymal phase NMUMG cell behavior, but did not fully
arrest TGF-b induced EMT progression, we next determined
whether the over-expression of mir-99a and mir-99b in epithelial
phase NMUMG cells could induce their transition into mesen-
chymal cells.
NMUMG migration was markedly increased by mir-99a and
mir-99b over-expression (Figure 5, B) which also resulted in down-
regulation of E-Cadherin and ZO-1 proteins (Figure 5D). In
contrast, actin distribution was not affected by mir-99a and mir-
99b over-expression (Figure 6A), as shown by concentrated actin
expression pattern at the epithelial junction, indicating that
NMUMG cells did not undergo EMT. Moreover, the expression
of known EMT markers Snail, Slug and Sip1 did not significantly
increase (Figure 6B). Interestingly we found that mir-99a and mir-
99b over-expression in epithelial phase NMUMG cells caused an
increase of the fibronectin expression (Figure 6B), which may
explain the increased migration observed in Figure 5A.
In addition, neither SMAD3 phosphorylation (Figure S2A) nor
TGF-b pathway activity (Figure S2B) was affected by mir-99a and
mir-99b over-expression either with or without TGF-b, suggesting
that mir-99a and mir-99b over-expression increased epithelial
NMUMG cells migration in a SMAD3-independent manner.
Taken together, these results suggest that while mir-99a and mir-
99b over-expression was not sufficient to induce completion of
EMT in epithelial phase NMUMG cells, it induced some molecular
and behavioral changes which are typical of partial EMT.
Mir-99a and mir-99b effects on proliferation and cell
cycle in NMUMG cells was epithelial or mesenchymal
phase-dependent
Next, we determined the role of mir-99a and mir-99b on cell
cycle and proliferation in epithelial versus mesenchymal phase
NMUMG cells. When cells were cultured with TGF-b (and thus
are in the mesenchymal phase) mir-99a and mir-99b over-
expression resulted in decreased cell proliferation, reduction of
cells in s-phase as well as reduced cyclin D1 expression
(Figure 7A,B). On the other hand in epithelial phase NMUMG
cells (cultured without TGF-b) mir-99a and mir-99b over-
expression stimulated cell proliferation (Figure 7D,E). These data
suggest that mir-99a and mir-99b over-expression affected cell
proliferation and cell cycle of NMUMG cells in a phase-dependent
manner, depending on whether cells are in the epithelial versus
mesenchymal phase.
Figure 2. Role of mir-99a and mir-99b inhibition on TGF-b pathway. (A) Luciferase assay with a PAI-promoter luciferase reported plasmid
shows that mir-99a and mir-99b blockade inhibits TGF-b pathway. (B) Inhibition of mir-99a and mir-99b with specific LNA antisense increases
proliferation of mesenchymal phase NMUMG. (C,D) Inhibition of mir-99a and mir-99b inhibits migration of mesenchymal phase NMUMG cells and
their adhesion abilities (E) (*=p,0.05).
doi:10.1371/journal.pone.0031032.g002
Figure 3. Mir-99a and mir-99b inhibition alters TGF-b induced
SMAD3. (A,B) Mir-99a and mir-99b inhibition reduces TGF-b activity by
inhibiting SMAD3 phosphorylation (*=p,0.05).
doi:10.1371/journal.pone.0031032.g003
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mesenchymal phase NMUMG cells by targetingt mTOR
gene
Having determined that either mir-99a and mir-99b over-
expression or mTOR knock-down resulted in inhibition of
mesenchymal phase NMUMG cell proliferation, we next
determined whether mir-99a and mir-99b stimulated the differ-
entiation of mesenchymal phase NMUMG cells into smooth
muscle cells. Mir-99a and mir-99b over-expression in NMUMG
cells induced the expression of a marker for mature smooth muscle
cells, transgelin (SM-22-a), (Figure 8A) [33] by targeting mTOR
gene (Figure 8B). Conversely, SM-22-a expression was inhibited
by the over-expression of mTOR in mesenchymal phase
NMUMG cells over-expressing mir-99a and mir-99b (Figure 8C).
Taken together, these data suggest that mir-99a and mir-99b could
induce mesenchymal phase NMUMG to fully differentiate into
smooth muscle cells by targeting the mTOR gene.
Identification of mir-99a and mir-99b targets
Micrornas target multiple genes simultaneously by binding to
the 39UTR portion of specific target mRNAs [34,35]. The seed
sequence of a microrna is responsible for mirna target identifica-
tion and is only 6–8 nucleotides long, thus micrornas can
potentially target hundreds if not thousands of messenger RNAs.
The biological activity of most mirnas results, therefore, from the
coordinated inhibition of different mRNA targets. In order to fully
understand the complete array of biological activities of mirnas it is
necessary to identify most of the mirna targets in our system. Mir-
99a and mir-99b have a unique seed sequence, and the number of
their predicted targets is quite small: 30 according to PicTar
software, http://pictar.mdc-berlin.de, 38 according to TargetScan
software, http://www.targetscan.org. We used a luciferase assay to
validate most of the putative mir-99a and mir-99b targets
(Figure 9A). We further validated mTOR gene as a target of
mir-99a and mir-99b by using Western blot approach (Figure 9B).
Furthermore, using a specific sirna against mTOR gene we were
able to replicate many of the effects of the mir-99a and mir-99b
over-expression, such as E-cadherin and ZO-1 down-regulation, in
epithelial phase NMUMG cells (Figure 5E). In contrast, mTOR
down-regulation per se did not affect proliferation (Figure 7D,E)
and migration (Figure 5A,B) of epithelial phase NMUMG cells
[28]. However, in mesenchymal phase NMUMG cells, mTOR
down-regulation affected cell proliferation and cell cycle concom-
itantly with the observed up-regulation of mir-99a and mir-99b
(Figure 6A,B,C).
Figure 4. Mir-99a and mir-99b inhibition does not block TGF-b induced EMT of NMUMG cells. F- actin and ZO-1 staining of untreated (t0)
(A) or TGF-b treated NMUMG cells for 24 h (B) or 48 h (C) shows that mir-99a and mir-99 inhibition does not block the transition of epithelial phase
NMUMG cells into mesenchymal cells.
doi:10.1371/journal.pone.0031032.g004
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and mir-99b increases the migration of epithelial phase NMUMG cells (*=p,0.05). (C) Mir-99a and mir-99b decreases E-cadherin, ZO-1 and Rock-1
protein expression level. (E) mTOR knockdown with sirna decreases expression of E-cadherin and ZO-1.
doi:10.1371/journal.pone.0031032.g005
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Since EMT plays a critical role in normal biological processes
and disease, understanding both its mechanisms and molecular
regulators/modulators is of general biological interest. One of the
well documented EMT inducing cytokine is TGF-b. TGF-b
signals through both SMAD-dependent and SMAD-independent
pathways in order to induce epithelial cells to become mesenchy-
mal cells, with characteristically increased migratory and meta-
static phenotypes. Many positive and negative modulators of the
TGF-b pathway have been described. For instance, TGF-b signals
through mTOR in a SMAD-independent way and in turn mTOR
negatively affects TGF-b signaling by inhibiting SMAD3 phos-
phorylation.
The discovery of mirnas as a new class of gene expression
regulators has further increased the complexity of regulatory
Figure 6. Mir-99a and mir-99b over-expression in epithelial NMUMG cells does not induce EMT. (A) F-actin staining of epithelial NMUMG
cells shows that actin filaments do not change when mir-99a and mir-99b are over-expressed, indicating that NMUMG cells are still epithelial. (B) Real
time PCR quantification of the transcriptional factors snail2, slug and sip1, showing no change of their expression, while over-expression of mir-99a
and mir-99b induces over-expression of fibronectin (*=p,0.05).
doi:10.1371/journal.pone.0031032.g006
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expression and activity has been documented [36] while the role of
particular mirnas on the TGF-b pathway is currently under study
[8]. For instance, the mir-200 family of micrornas is down-
regulated during TGF-b induced EMT in NMUMG cells; while
over-expression of these micrornas inhibites EMT [21]. Moreover,
Martello et al. has determined that mir-103/107 induces EMT in
mammary gland cells by down-regulating DICER gene expression
[12].
Herein, we identified mir-99a and mir-99b as two new mirnas
that function as downstream regulators in the TGF-b pathway,
based upon the observation that TGF-b increased the expression
of both mir-99a and mir-99b in NMUMG cells undergoing EMT.
However, we could not establish whether mir-99a and mir-99b are
Figure 7. Mir-99a and mir-99b effects on proliferation and cell cycle in NMUMG cells is epithelial or mesenchymal phase-
dependent. (A,B,C) Either over-expression of mir-99a and mir-99b or mTOR knock-down in mesenchymal phase NMUMG cells decreases cell
proliferation. (D,E) In epithelial phase NMUMG cells, mir-99a and mir-99b over-expression increases cell proliferation (*=p,0.05).
doi:10.1371/journal.pone.0031032.g007
MIR-99a and MIR-99b on TGF-Beta Pathway
PLoS ONE | www.plosone.org 10 January 2012 | Volume 7 | Issue 1 | e31032directly regulated by TGF-b, because the mir-99a and mir-99b
promoters have yet to be characterized.
To determine the role of mir-99a and mir-99b in TGF-b
signaling and EMT processes we inhibited mir-99a and mir-99b
activity with LNA antisense probes or conversely increased their
expression in NMUMG cells. We found that mir-99a and mir-99b
are important components of the TGF-b pathway because
inhibition of mir-99a and mir-99b negatively affected TGF-b
pathway in NMUMG cells as evidenced by a luciferase activity
assay. In addition, TGF-b induced migration and adhesion of
NMUMG cells were inhibited upon inhibition of mir-99a and mir-
99b, which further confirms that mir-99a and mir-99b activity is
necessary for normal TGF-b signaling in mammary gland cells.
We used human breast cancer cells 4T1 to validate that mir-99a
and mir-99b inhibition negatively affected TGF-b signaling and
cell wound-healing abilities (Figure S1A,B). Our data suggest that
mir-99b and mir-99b may affect TGF-b signaling pathway by
altering the phosphorylation of SMAD3.
Mir-99a and mir-99b blockade resulted in inhibition of TGF-b
pathway activity (Figure 2A) and decreased SMAD3 phosphory-
lation (Figure 3A,B). On the other hand, when mir-99a and mir-
99b were up-regulated, TGF-b signaling pathway and SMAD3
phosphorylation were not altered (Figure S2A,B). This contradic-
tion can be explained by assuming that mir-99a and mir-99b have
strong binding affinities for the mRNA gene targets which then
alter TGF-b activity and SMAD3 phosphorylation. In this
scenario most available mir-99a and mir-99b binding sites would
be already ‘‘saturated’’, thus the TGF-b signaling pathway would
Figure 8. Mir-99a and mir-99b over-expression in mesenchymal phase NMUMG cells. (A) Over-expression of mir-99a and mir-99b in
mesenchymal phase NMUMG induces expression of SM-22-a. (B,C) Over-expression of mTOR in mir-99a and mir-99b treated mesenchymal phase
NMUMG inhibited SM-22-a expression. (D) mTOR protein expression intensity quantified by western blot to confirm adenoviral mediated mTOR over-
expression.
doi:10.1371/journal.pone.0031032.g008
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de-saturation of the mirnas binding sites
Currently, the target of mir-99a and mir-99b that is responsible
for altered SMAD3 phosphorylation is still unknown, and it is
unlikely that only one target for mir-99a and mir-99b target is
responsible for the altered SMAD3 phosphorylation. Several mir-
99a and mir-99b targets are known to affect TGF-b signaling
pathway, including mTOR, CTDSPL, CALM, PAM and
FOXA1. Thus, multiple mir-99a and mir-99b targets are likely
to impinge on the TGF-b pathway and be responsible for
decreased SMAD3 phosphorylation when mir-99a and mir-99b
are inhibited.
It is also noteworthy that, although mir-99a and mir-99b
inhibition altered TGF-b signaling, it did not fully inhibit EMT
progression in of NMUMG cells.
Interestingly, in epithelial NMUMG cells mir-99a and mir-99b
over-expression increased migration, as evidenced by down-
regulation of E-cadherin and ZO-1 and increased fibronectin
expression. However NMUMG cells remained epithelial as
indicated by undetectable changes of both F-actin staining pattern
and expression levels transcriptional factors involved in the EMT
process, such as snail1, slug and sip1. We, therefore speculate that
the down-regulation of E-cadherin and ZO-1 resulting from over-
expression of mir-99a and mir-99b is probably caused through
mTOR, because mTOR is a target of mir-99a and mir-99b, and
its down-regulation decreases E-cadherin and ZO-1 expression in
epithelial phase NMUMG cells (Figure 5D). Moreover Bieri et al.
have identified mTOR as a critical regulator of VE-Cadherin
expression in HUVEC cells [37]. Unexpectedly, we found that
mTOR down-regulation alone was not sufficient to increase
epithelial NMUMG migration as also previously reported by
others [28]. Thus, we concluded that mir-99a and mir-99b must
be targeting other genes, in addition to mTOR, to promote
migration of epithelial phase NMUMG cells.
Herein, we found that mir-99a and mir-99b affect cell
proliferation in a cell phase dependent manner, depending on
whether NMUMG cells are epithelial or mesenchymal. When
NMUMG are epithelial, mir-99a and mir-99b stimulate cell
proliferate; while they inhibit cell proliferation in mesenchymal
NMUMG cells. By comparing cell proliferation data obtained
after mir-99a and mir-99b over-expression and sirna induced
mTOR knock-down, we concluded that mTOR gene is likely the
principal target of mir-99a and mir-99b when culturing NMUMG
with TGF-b (and therefore mesenchymal cells). This conclusion is
confirmed by the observation that over-expression of mir-99a and
mir-99b mimicked many effects of mTOR knock-down with a
specific sirna. In contrast, in epithelial phase NMUMG cells, mir-
99a and mir-99b are targeting at least one gene other than
mTOR, whose inhibition is likely responsible for the increased
migration and proliferation of epithelial NMUMG cells [28]. We
have validated most of the hypothetical mir-99a and mir-99b
target genes identified in silico (Figure 9A), and inhibition of some
of those target genes in epithelial phase NMUMG cells may result
in the increased cell proliferation and migration that we observed
in our experiments.
Finally, we found that either mTOR down-regulation or mir-
99a and mir-99b over-expression, in mesenchymal NMUMG cells
resulted in increased expression of SM-22-a (transgelin), a marker
of fully differentiated and contractile smooth muscle cells.
Conversely, over-expression of mTOR gene resulted in down-
regulation of SM-22-a expression, suggesting that mTOR also
directly regulate SM-22-a expression in mesenchymal NMUMG
cells. Consistent with our data, mTOR has been previously
identified as a key gene involved in smooth muscle cell
differentiation [38].
In conclusion, we have identified mir-99a and mir-99b as two
novel effectors of the TGF-b pathway during EMT in NMUMG
cells. Mir-99a and mir-99a are, in turn, positive modulators of the
TGF-b pathway itself and also regulators of cell proliferation and
migration of both epithelial and mesenchymal phase NMUMG
cells. We speculate that, mir-99a and mir-99b may play key roles
in cancer development and progression, as well as in embryonic
development by modulating TGF-b signaling. In addition, the
identification of mTOR gene as a notable target of mir-99a and
mir-99b opens the door to the possibility of therapeutic
applications for mir-99a and mir-99b in cancer-like diseases such
as Lymphangiomyelomatosis.
Supporting Information
Figure S1 Mir-99a and mir-99b blockade inhibits TGF-b
induced migration of 4T1 cells. (A, B) Blockade of mir-99a
and mir-99b inhibits TGF-b induced migration of 4T1 cells
migration in a wound healing assay.
(TIF)
Figure S2 Mir-99a and mir-99b over-expression does
not affect TGF-b pathway. (A) NMUMG cells over-expression
mir-99a, mir-99b or a control mirna are pulsed with TGF-b for
1 h. SMAD3 phosphorylation is quantified by Western blot. (B)
TGF-b pathway activity is quantified using 3TP-lux plasmid assay.
NMUMG cells over-expressing mir-99a, mir-99b or a control
mirna do not show changes the TGF-b pathway activity.
(TIF)
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